This content is in French.
HIV and Dual Therapy: a promising step towards maintaining viral suppression
5 décembre 2024

The introduction of dual therapies in HIV
treatment marks a significant advance in optimizing care. By reducing the
number of drugs used, these simplified regimens improve tolerance, lower costs,
and simplify treatment management. Compared to traditional triple therapies,
dual therapies promote better adherence and allow for personalized care
tailored to patients' needs, while maintaining comparable efficacy in viral
suppression. This approach combines innovation, patient comfort, and
sustainability for healthcare systems.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Marinosci, A., et al. (2024). Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial. Open forum infectious diseases, 11(11), ofae61
View the sourceOther recent articles

Psychological Therapies for Adults With ADHD: Meaningful Benefits, but Persistent Gaps in Outcomes
14 octobre 2026

Beyond Recovery: How Exercise-Based Cardiac Rehabilitation Improves Outcomes in Coronary Heart Disease
14 octobre 2026

Bowel Endometriosis: From Gastrointestinal Symptoms to Diagnosis and Management
9 octobre 2026
